Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: A molecular epidemiological study

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 5, 2014, Pages 1322-1330

  Willmann, Matthias ^a,b   Bezdan, Daniela ^c,d   Zapata, Luis ^c,d   Susak, Hana ^c,d   Vogel, Wichard ^e   Schröppel, Klaus ^a   Liese, Jan ^a,b   Weidenmaier, Christopher ^a,b   Autenrieth, Ingo B ^a,b   Ossowski, Stephan ^c,d   Peter, Silke ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b German Center for Infection Research (DZIF)   (Germany)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

IMP carbapenemase; Outbreak investigation; Transmission analysis; Whole genome sequencing

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; IMP 8 PROTEIN; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; EPIDEMIC; GENE SEQUENCE; GERMANY; HUMAN; INFECTION CONTROL; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PHYLOGEOGRAPHY; PSEUDOMONAS INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL; WARD; BACTERIAL GENOME; CLASSIFICATION; DISEASE TRANSMISSION; DNA SEQUENCE; DRUG EFFECTS; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPATIOTEMPORAL ANALYSIS; TRANSMISSION;

DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; EPIDEMIOLOGIC STUDIES; GENOME, BACTERIAL; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA; SPATIO-TEMPORAL ANALYSIS;

EID: 84929761226     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku546     Document Type: Article

References (42)

1. ECDC. Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals. 2013. http://www. ecdc.europa.eu/en/publications/Publications/healthcare-associatedinfections- antimicrobial-use-PPS.pdf.
2. ECDC. Antimicrobial Resistance Surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2013. http://ecdc.europa.eu/en/publications/Publications/ antimicrobial-resistance-surveillance-europe-2012.pdf.
3. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
4. Aloush V, Navon-Venezia S, Seigman-Igra Y et al. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 2006; 50: 43-8.
5. Tam VH, Rogers CA, Chang KT et al. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother 2010; 54: 3717-22.
6. Tumbarello M, Repetto E, Trecarichi EM et al. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect 2011; 139: 1740-9.
7. Morales E, Cots F, Sala M et al. Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. BMC Health Serv Res 2012; 12: 122.
8. Corvec S, Poirel L, Espaze E et al. Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme. J Hosp Infect 2008; 68: 73-82.
9. Snyder LA, Loman NJ, Faraj LA et al. Epidemiological investigation of Pseudomonas aeruginosa isolates from a six-year-long hospital outbreak using high-throughput whole genome sequencing. Euro Surveill 2013; 18: pii1/420611.
10. Loveday HP, Wilson JA, Kerr K et al. Association between healthcare water systems and Pseudomonas aeruginosa infections: a rapid systematic review. J Hosp Infect 2014; 86: 7-15.
11. Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469-74.
12. Koser CU, Holden MT, Ellington MJ et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012; 366: 2267-75.
13. Gardy JL, Johnston JC, Ho Sui SJ et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 2011; 364: 730-9.
14. Snitkin ES, Zelazny AM, Thomas PJ et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012; 4: 148ra116.
15. Nubel U, Roumagnac P, Feldkamp M et al. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2008; 105: 14130-5.
16. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters. 2012. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_ files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf.
17. EUCAST. Antimicrobial Susceptibility Testing-EUCAST Disk Diffusion Method Version 4.0. 2014. http://www.eucast.org/fileadmin/src/media/ PDFs/EUCAST_files/Disk_test_documents/Version_4/Manual_v_4.0_EUCAST_Disk_Test.pdf.
18. Leclercq R, Canton R, Brown DF et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013; 19: 141-60.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, USA, 2013.
20. Luo R, Liu B, Xie Y et al. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience 2012; 1: 18.
21. Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 2010; 5: e11147.
22. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9: 357-9.
23. Li H, Handsaker B, Wysoker A et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078-9.
24. Marttinen P, Hanage WP, Croucher NJ et al. Detection of recombination events in bacterial genomes from large population samples. Nucleic Acids Res 2012; 40: e6.
25. Zhou Y, Liang Y, Lynch KH et al. PHAST: a fast phage search tool. Nucleic Acids Res 2011; 39: W347-52.
26. Marvig RL, Johansen HK, Molin S et al. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet 2013; 9: e1003741.
27. Yang L, Jelsbak L, Marvig RL et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 2011; 108: 7481-6.
28. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-b-lactamases: a last frontier for b-lactams? Lancet Infect Dis 2011; 11: 381-93.
29. Peter S, Wolz C, Kaase M et al. Emergence of Citrobacter freundii carrying IMP-8 metallo-b-lactamase in Germany. New Microbes New Infect 2013; 2: 42-5.
30. Witney AA, Gould KA, Pope CF et al. Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa. Clin Microbiol Infect 2014; 20: O609-18.
31. Jombart T, Eggo RM, Dodd PJ et al. Reconstructing disease outbreaks from genetic data: a graph approach. Heredity (Edinb) 2011; 106: 383-90.
32. Trias J, Nikaido H. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990; 34: 52-7.
33. Trias J, Nikaido H. Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J Biol Chem 1990; 265: 15680-4.
34. Ochs MM, Bains M, Hancock RE. Role of putative loops 2 and 3 in imipenem passage through the specific porin OprD of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000; 44: 1983-5.
35. Huang H, Jeanteur D, Pattus F et al. Membrane topology and sitespecific mutagenesis of Pseudomonas aeruginosa porin OprD. Mol Microbiol 1995; 16: 931-41.
36. Skurnik D, Roux D, Cattoir V et al. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc Natl Acad Sci USA 2013; 110: 20747-52.
37. Khatua B, Vleet JV, Choudhury BP et al. Sialylation of outer membrane porin protein D: a mechanistic basis of antibiotic uptake in Pseudomonas aeruginosa. Mol Cell Proteomics 2014; 13: 1412-28.
38. Sjoberg BM, Torrents E. Shift in ribonucleotide reductase gene expression in Pseudomonas aeruginosa during infection. Infect Immun 2011; 79:2663-9.
39. Lee KM, Go J, Yoon MY et al. Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa. Infect Immun 2012; 80: 1639-49.
40. Willmann M, Kuebart I, Marschal M et al. Effect of metallo-b-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study. BMC Infect Dis 2013; 13: 515.
41. Vardakas KZ, Rafailidis PI, Konstantelias AA et al. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria:the study, the patient, the bug or the drug? J Infect 2013; 66:401-14.
42. Tacconelli E, Cataldo MA, Dancer SJ et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20: 1-55.